Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Parkinsonism & Related Disorders

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.parkreldis.2014.02.010PMID 24637128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism.

  2013cited by this paper
• Neuropathologic analysis of Lewy‐related α‐synucleinopathy in olfactory mucosa

  2013cited by this paper
• Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.

  2013cited by this paper
• Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease

  2011cited by this paper
• Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease?

  2011cited by this paper
• Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease

  2010cited by this paper
• Olfactory dysfunction and cardiovascular dysautonomia in Parkinson’s disease

  2010cited by this paper
• Olfactory dysfunction as a diagnostic marker for Parkinson’s disease

  2009cited by this paper
• Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease.

  2009cited by this paper
• Association of olfactory dysfunction with risk for future Parkinson's disease

  2008cited by this paper
• Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease

  2008cited by this paper
• Smell identification in Japanese Parkinson's disease patients: using the odor stick identification test for Japanese subjects.

  2008cited by this paper
• Dobutamine stress test unmasks cardiac sympathetic denervation in Parkinson's disease.

  2007cited by this paper
• Parkinson's disease: a dual‐hit hypothesis

  2007cited by this paper
• Degeneration of Cardiac Sympathetic Nerve Begins in the Early Disease Process of Parkinson’s Disease

  2007cited by this paper
• Cardiovascular dysautonomia in de novo Parkinson's disease.

  2006cited by this paper
• Correlation between cardiac 123I‐MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy

  2006cited by this paper
• Prognosis of Parkinson's disease: Time to stage III, IV, V, and to motor fluctuations

  2006cited by this paper
• α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects

  2006cited by this paper
• FP‐CIT and MIBG scintigraphy in early Parkinson's disease

  2005cited by this paper
• Blood pressure recovery from Valsalva maneuver in patients with autonomic failure

  2005cited by this paper
• How to diagnose MSA early: the role of magnetic resonance imaging

  2005cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases

  1999cited by this paper
• Clinical and physiological characteristics of autonomic failure with Parkinson's disease

  1999cited by this paper
• Olfactory dysfunction in Parkinson's disease.

  1997cited by this paper
• Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology.

  1996cited by this paper
• Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy

  1996cited by this paper
• Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure.

  1991cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Assessment of autonomic function in humans by heart rate spectral analysis.

  1985cited by this paper

• Evaluating the Utility of Wearable Sensors for the Early Diagnosis of Parkinson Disease: Systematic Review

  2025cites this paper
• B-type natriuretic peptide in Parkinson's disease: a novel biomarker of dysautonomia.

  2025cites this paper
• Epidemiology of autonomic dysfunction in Parkinson's disease (Review)

  2025cites this paper
• The noradrenergic subtype of Parkinson disease: from animal models to clinical practice

  2023cites this paper
• Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysis

  2023cites this paper
• Correlation of olfactory function factors with cardiac sympathetic denervation in Parkinson’s disease

  2023cites this paper
• Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review

  2023cites this paper
• Interactive effect of orthostatic hypotension on gray matter atrophy associated with hyposmia and RBD in de novo Parkinson’s disease

  2023cites this paper
• Reply to the Letter to the Editor “The Microbiota in Parkinson’s Disease: Ranking the Risk of Heart Disease”

  2022cites this paper
• Clinical and neuroendocrinological characteristics of delayed orthostatic hypotension in Parkinson’s disease

  2021cites this paper
• Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern

  2021cites this paper
• Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation Carriers

  2021cites this paper
• Difference in cardiovascular response during orthostatic stress in Parkinson’s disease and multiple system atrophy

  2020cites this paper
• Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid

  2019cites this paper
• Association between autonomic dysfunction and olfactory dysfunction in Parkinson’s disease in southern Chinese

  2019cites this paper
• Rapid-Eye-Movement Sleep Behavior Disorder

  2019cites this paper
• Optimizing Parkinson’s disease diagnosis: the role of a dual nuclear imaging algorithm

  2018influential citation
• Role of myocardial 123I-mIBG innervation imaging in the diagnosis of neurodegenerative diseases

  2018cites this paper
• Findings of 123I-MIBG Cardiac Scintigraphy: Parkinson’s Disease and Related Disorders and Others (RBD, Cardiac Diseases, DM, etc.)

  2017cites this paper
• Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson’s disease

  2017cites this paper
• Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?

  2017cites this paper
• Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study.

  2017cites this paper
• Pattern of Reduced Functional Connectivity and Structural Abnormalities in Parkinson’s Disease: An Exploratory Study

  2017cites this paper
• Nonmotor Subtyping in Parkinson's Disease.

  2017cites this paper
• Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson’s disease

  2017cites this paper
• Spotlight on olfactory dysfunction in Parkinson's disease

  2017cites this paper
• Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms.

  2017cites this paper
• Association between changes in visual evoked magnetic fields and non-motor features in Parkinson’s disease

  2017cites this paper
• (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies.

  2016cites this paper
• Serum Tyrosine-to-Phenylalanine Ratio is Low in Parkinson’s Disease

  2016cites this paper
• Heart rate variability to differentiate essential tremor from early-stage tremor-dominant Parkinson's disease.

  2016cites this paper
• Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson’s Disease and Atypical Parkinsonian Syndromes

  2016cites this paper
• Olfactory dysfunction in dementia.

  2014cites this paper
• Peripheral and cognitive signs: delineating the significance of impaired catecholamine metabolism in Parkinson's disease progression

  2014cites this paper